ZA8803653B - Prostaglandin-lipid formulations - Google Patents

Prostaglandin-lipid formulations

Info

Publication number
ZA8803653B
ZA8803653B ZA883653A ZA8803653A ZA8803653B ZA 8803653 B ZA8803653 B ZA 8803653B ZA 883653 A ZA883653 A ZA 883653A ZA 8803653 A ZA8803653 A ZA 8803653A ZA 8803653 B ZA8803653 B ZA 8803653B
Authority
ZA
South Africa
Prior art keywords
prostaglandin
lipid formulations
lipid
formulations
Prior art date
Application number
ZA883653A
Inventor
Robert P Lenk
P Lenk Robert
Michelle M Tomsho
M Tomsho Michelle
Robert L Suddith
L Suddith Robert
Robert J Klimchak
J Klimchak Robert
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US5330587A priority Critical
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of ZA8803653B publication Critical patent/ZA8803653B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes
    • A61K9/1278Post-loading, e.g. by ion or pH gradient
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/829Liposomes, e.g. encapsulation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]
ZA883653A 1987-05-22 1988-05-23 Prostaglandin-lipid formulations ZA8803653B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US5330587A true 1987-05-22 1987-05-22

Publications (1)

Publication Number Publication Date
ZA8803653B true ZA8803653B (en) 1989-03-29

Family

ID=21983292

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA883653A ZA8803653B (en) 1987-05-22 1988-05-23 Prostaglandin-lipid formulations

Country Status (13)

Country Link
US (1) US5082664A (en)
EP (1) EP0292403B1 (en)
KR (2) KR970005171B1 (en)
AT (1) AT109982T (en)
AU (1) AU617678B2 (en)
CA (1) CA1323838C (en)
DE (2) DE3851090T2 (en)
ES (1) ES2058317T3 (en)
FI (1) FI95199C (en)
HK (1) HK1007496A1 (en)
PT (1) PT87545B (en)
WO (1) WO1988009170A1 (en)
ZA (1) ZA8803653B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9203808A (en) * 1987-03-05 1992-07-01 Liposome Co Inc Formulations of high drug: lipid, liposomal-antineoplastic agents.
US5811118A (en) * 1987-05-22 1998-09-22 The Liposome Company, Inc. Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
DE3910761C2 (en) * 1989-04-04 1991-11-14 Bodo Dr.Med. 4018 Langenfeld De Melnik
AT135207T (en) * 1989-04-04 1996-03-15 Beiersdorf Ag Means for atopy prophylaxis
US5591446A (en) * 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
JPH0395118A (en) * 1989-09-07 1991-04-19 Green Cross Corp:The Prostaglandin-containing liposome preparation
US5882678A (en) * 1990-01-12 1999-03-16 The Liposome Co, Inc. Interdigitation-fusion liposomes containing arachidonic acid metabolites
AT176401T (en) * 1991-05-07 1999-02-15 Liposome Co Inc liposomal prostaglandin formulations
DE4125255A1 (en) * 1991-07-31 1993-02-04 Knoll Ag Prostaglandin E (down arrow) 1 (down arrow) formulation
JP3168550B2 (en) * 1992-12-02 2001-05-21 株式会社林原生物化学研究所 Dehydration method and the dehydration product obtained by the process of dehydrating agent and hydrate to use it
US6005100A (en) * 1992-12-02 1999-12-21 Kabushiki Kaisha Hayashibara Seitbutsu Kagaku Kenkyujo Trehalose composition for prolonging product shelf life
WO1994022430A1 (en) * 1993-04-02 1994-10-13 The Liposome Company, Inc. Method of producing liposomes
PT707472E (en) 1993-07-08 2001-07-31 Liposome Co Inc Process for controlling the size of liposomes
US5853755A (en) * 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
DE69421936T2 (en) * 1993-10-27 2000-06-29 Upjohn Co Stabilized prostaglandin E1
DK0726764T3 (en) * 1993-11-04 1999-12-20 Liposome Co Inc The multilamellar liposomal arachidonic acid metabolite
AT176397T (en) * 1993-11-16 1999-02-15 Liposome Co Inc Arachidonic acid-containing interdigitation-fusion liposomes
US5840328A (en) * 1994-01-11 1998-11-24 The Liposome Company, Inc. Treatment using arachidonic acid metabolite and particulate formulations
US5716526A (en) * 1994-01-14 1998-02-10 The Liposome Company, Inc. Method of separating materials from liposomes or lipid complexes
EP0783295A1 (en) * 1994-09-23 1997-07-16 The Liposome Company, Inc. Method of producing a lyophilized liposome product
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
US6447800B2 (en) * 1996-01-18 2002-09-10 The University Of British Columbia Method of loading preformed liposomes using ethanol
US5980551A (en) * 1997-02-07 1999-11-09 Endovasc Ltd., Inc. Composition and method for making a biodegradable drug delivery stent
US6001333A (en) * 1997-09-12 1999-12-14 See; Jackie R. Methods of preparing micro encapsulated agents for use in the detection of tumors by CT imaging
US6019999A (en) * 1997-12-03 2000-02-01 Miller; David F. Process for making liposomal ion-exchange whey protein and products thereof
JP2003342196A (en) * 2002-05-31 2003-12-03 Mukku:Kk Composition for intravenous injection, method of production for the same and its preparation
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
AT549014T (en) * 2006-09-05 2012-03-15 Q P Corp Prostaglandine fat emulsion, method for the production thereof, method for their stabilization and emulsified medium
US20090035725A1 (en) * 2007-08-02 2009-02-05 Ondine International, Ltd. Photodisinfection of oral cavity
WO2010034837A1 (en) * 2008-09-26 2010-04-01 Phares Pharmaceutical Research N.V. Method of solubilising biologically active compounds
US9835618B1 (en) * 2009-02-06 2017-12-05 Los Alamos National Security, Llc Discovery, detection and use of biomarkers
IT1397867B1 (en) * 2010-02-03 2013-02-04 Brotzu Liposomes containing prostaglandin E1 (PGE1), formulations containing them and their use
SG187770A1 (en) * 2010-08-12 2013-03-28 Univ Nanyang Tech A liposomal formulation for ocular drug delivery
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery
US9962393B1 (en) * 2015-06-21 2018-05-08 Angiosoma Research, Inc. Method for treating vascular disease by administering a liposomal prostaglandin composition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2274122B1 (en) * 1974-06-07 1976-10-15 Cgr Mev
US3993754A (en) * 1974-10-09 1976-11-23 The United States Of America As Represented By The United States Energy Research And Development Administration Liposome-encapsulated actinomycin for cancer chemotherapy
US4086257A (en) * 1976-10-12 1978-04-25 Sears Barry D Phosphatidyl quaternary ammonium compounds
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
CH621479A5 (en) * 1977-08-05 1981-02-13 Battelle Memorial Institute
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
JPH0240644B2 (en) * 1979-05-02 1990-09-12 Kureha Chemical Ind Co Ltd
JPH0157094B2 (en) * 1982-06-18 1989-12-04 Taisho Seiyaku Kk
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
WO1985000968A1 (en) * 1983-09-06 1985-03-14 Health Research, Inc. Liposome delivery method for decreasing the toxicity of an antitumor drug
JPH0818989B2 (en) * 1984-01-12 1996-02-28 大正製薬株式会社 Method for stabilizing prostaglandin fat emulsion
US4721612A (en) * 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes
CA1264668A (en) * 1984-06-20 1990-01-23 Pieter R. Cullis Extrusion techniques for producing liposomes
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
CA1270198A (en) * 1984-08-08 1990-06-12 Marcel B. Bally Encapsulation of antineoplastic agents in liposomes
JPH0362696B2 (en) * 1984-10-22 1991-09-26 Ono Pharmaceutical Co
DE3689769T2 (en) * 1985-07-05 1994-07-21 Liposome Co Inc Multilamellar liposome with improved einschliessungswirkung.

Also Published As

Publication number Publication date
EP0292403A2 (en) 1988-11-23
DE3851090T2 (en) 1995-01-12
EP0292403A3 (en) 1988-12-21
HK1007496A1 (en) 1999-04-16
WO1988009170A1 (en) 1988-12-01
ES2058317T3 (en) 1994-11-01
FI95199B (en) 1995-09-29
EP0292403B1 (en) 1994-08-17
FI95199C (en) 1996-01-10
DE3851090D1 (en) 1994-09-22
PT87545A (en) 1989-05-31
KR890701093A (en) 1989-12-19
FI895554A0 (en) 1989-11-21
PT87545B (en) 1992-12-31
AU617678B2 (en) 1991-12-05
CA1323838C (en) 1993-11-02
US5082664A (en) 1992-01-21
FI895554D0 (en)
AU1954588A (en) 1988-12-21
KR970005171B1 (en) 1997-04-14
AT109982T (en) 1994-09-15

Similar Documents

Publication Publication Date Title
DE3868121D1 (en) Polyaetherthioaether-esteramide
AR243722A1 (en) Chemical formulations
GB8720411D0 (en) Polyimide-siloxanes
EP0294647A3 (en) Thiadiazinones
EP0303867A3 (en) Edgedrain
EP0287794A3 (en) Dosage-syringe
CY1658A (en) 1-phenyl-3-naphthalenyloxy-propanamines
EP0288268A3 (en) 4-demethoxy-4-amino-anthracyclines
ZA8803653B (en) Prostaglandin-lipid formulations
EP0315050A3 (en) Alcenyl bicyclohexanes
EP0312727A3 (en) Combine-harvester
GB8708098D0 (en) Timeswitches
EP0289356A3 (en) Pesticidal formulations
GB8708539D0 (en) Duckboard
EP0295062A3 (en) Polysilacyclobutasilazanes
EP0295061A3 (en) Polydisilacyclobutasilazanes
DE3855863D1 (en) Hydroxaminsäureabkömmling
GB2206350B (en) Anticellulitic l-hydroxyalkyl-xanthines
GB2208385B (en) Pyridyl-ethers
GB2202223B (en) Sulfonylcarboxamides
GB8718265D0 (en) Pontentiometer
GB8714363D0 (en) Lintelform
GB8702288D0 (en) Cinnoline-carboxamides
EP0291284A3 (en) Dispenser-applicator
GB2219343B (en) Doorstays